These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 27771172)

  • 21. Clinical study of children with Takayasu arteritis: a retrospective study from a single center in China.
    Feng Y; Tang X; Liu M; Zhou J; Zhao X; Li Q
    Pediatr Rheumatol Online J; 2017 Apr; 15(1):29. PubMed ID: 28416004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclophosphamide for large vessel vasculitis: assessment of response by PET/CT.
    Henes JC; Mueller M; Pfannenberg C; Kanz L; Kötter I
    Clin Exp Rheumatol; 2011; 29(1 Suppl 64):S43-8. PubMed ID: 21385544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MRI parametric monitoring of biological therapies in primary large vessel vasculitides: a pilot study.
    Spira D; Xenitidis T; Henes J; Horger M
    Br J Radiol; 2016; 89(1058):20150892. PubMed ID: 26649990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of refractory Takayasu arteritis with tocilizumab: 7 Italian patients from a single referral center.
    Tombetti E; Franchini S; Papa M; Sabbadini MG; Baldissera E
    J Rheumatol; 2013 Dec; 40(12):2047-51. PubMed ID: 24187104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The study of novel inflammatory markers in takayasu arteritis and its correlation with disease activity.
    Pathadan AP; Tyagi S; Gupta MD; M P G; Mahajan S; Kunal S; Mahajan B; Bansal A
    Indian Heart J; 2021; 73(5):640-643. PubMed ID: 34627584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum levels of fetuin-A as a novel biomarker for disease activity in patients with Takayasu arteritis and granulomatous polyangiitis.
    Karadeniz H; Güler AA; Koca G; Salman RB; Satış H; Ataş N; Babaoğlu H; Paşaoğlu H; Küçük H; Tufan A; Öztürk MA; Göker B; Haznedaroğlu Ş
    Clin Rheumatol; 2022 Apr; 41(4):1169-1176. PubMed ID: 35013833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Refractory Takayasu arteritis successfully treated with infliximab.
    Maffei S; Di Renzo M; Santoro S; Puccetti L; Pasqui AL
    Eur Rev Med Pharmacol Sci; 2009; 13(1):63-5. PubMed ID: 19364087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Are monocyte-to-HDL and C-reactive protein-to-albumin ratios useful for the diagnosis and follow-up of Takayasu arteritis?
    Kılınç EA; Varkal G; Kırmızıer G; Türk İ; Özer HTE
    Rev Assoc Med Bras (1992); 2024; 70(5):e20231683. PubMed ID: 38775535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rescue treatment with tocilizumab for Takayasu arteritis resistant to TNF-α blockers.
    Salvarani C; Magnani L; Catanoso MG; Pipitone N; Versari A; Dardani L; Pulsatelli L; Meliconi R; Boiardi L
    Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S90-3. PubMed ID: 22410150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TNF inhibitors appear to inhibit disease progression and improve outcome in Takayasu arteritis; an observational, population-based time trend study.
    Gudbrandsson B; Molberg Ø; Palm Ø
    Arthritis Res Ther; 2017 May; 19(1):99. PubMed ID: 28521841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential Role of Macrophage Phenotypes and CCL2 in the Pathogenesis of Takayasu Arteritis.
    Kong X; Xu M; Cui X; Ma L; Cheng H; Hou J; Sun X; Ma L; Jiang L
    Front Immunol; 2021; 12():646516. PubMed ID: 34079541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Efficacy and safety of tocilizumab in patients with Takayasu arteritis].
    Liao H; Pan LL; Du J; Gao N; Wang T
    Zhonghua Nei Ke Za Zhi; 2019 Jun; 58(6):444-448. PubMed ID: 31159524
    [No Abstract]   [Full Text] [Related]  

  • 33. Rapid control of disease activity by tocilizumab in 10 'difficult-to-treat' cases of Takayasu arteritis.
    Goel R; Danda D; Kumar S; Joseph G
    Int J Rheum Dis; 2013 Dec; 16(6):754-61. PubMed ID: 24382284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-tumour necrosis factor therapy in patients with refractory Takayasu arteritis: long-term follow-up.
    Molloy ES; Langford CA; Clark TM; Gota CE; Hoffman GS
    Ann Rheum Dis; 2008 Nov; 67(11):1567-9. PubMed ID: 18677012
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Chronic periodontitis with Takayasu arteritis: a case report].
    Gao W; Luan QX
    Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Oct; 47(5):875-7. PubMed ID: 26474634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Takayasu arteritis: anti-TNF therapy in a Brazilian setting.
    Nunes G; Neves FS; Melo FM; de Castro GR; Zimmermann AF; Pereira IA
    Rev Bras Reumatol; 2010; 50(3):291-8. PubMed ID: 21125165
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of plateletcrit in Takayasu arteritis: A potential biomarker for disease activity and 6-month treatment response.
    Sun Y; Cui X; Kong X; Chen H; Wu S; Ma L; Ding Z; Jiang L
    Int J Rheum Dis; 2023 Dec; 26(12):2517-2525. PubMed ID: 37875306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of immunosuppressive therapy on clinical, immunological, and angiographic outcome in active Takayasu's arteritis.
    Valsakumar AK; Valappil UC; Jorapur V; Garg N; Nityanand S; Sinha N
    J Rheumatol; 2003 Aug; 30(8):1793-8. PubMed ID: 12913937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of (18) F-fluorodeoxyglucose-positron emission tomography in the assessment of disease activity in patients with takayasu arteritis.
    Lee KH; Cho A; Choi YJ; Lee SW; Ha YJ; Jung SJ; Park MC; Lee JD; Lee SK; Park YB
    Arthritis Rheum; 2012 Mar; 64(3):866-75. PubMed ID: 21989701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High Levels of Circulating Endothelial Progenitor Cells Are Associated with Acrotism in Patients with Takayasu Arteritis.
    Keşkek ŞÖ; Bozkırlı-Ersözlü ED; Kozanoglu I; Yücel AE
    Med Princ Pract; 2017; 26(2):132-138. PubMed ID: 27816980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.